T. Hobday Et Al. , "Post-Progression Therapies in Patients with Advanced Neuroendocrine Tumors (NET): Analysis From the RADIANT-2 Trial," 76th Annual Scientific Meeting of the American-College-of-Gastroenterology , vol.106, Washington, Kiribati, 2011
Hobday, T. Et Al. 2011. Post-Progression Therapies in Patients with Advanced Neuroendocrine Tumors (NET): Analysis From the RADIANT-2 Trial. 76th Annual Scientific Meeting of the American-College-of-Gastroenterology , (Washington, Kiribati).
Hobday, T., Becerra, C., YALÇIN, Ş., Panneerselvam, A., Saletan, S., & Hainsworth, J., (2011). Post-Progression Therapies in Patients with Advanced Neuroendocrine Tumors (NET): Analysis From the RADIANT-2 Trial . 76th Annual Scientific Meeting of the American-College-of-Gastroenterology, Washington, Kiribati
Hobday, Timothy Et Al. "Post-Progression Therapies in Patients with Advanced Neuroendocrine Tumors (NET): Analysis From the RADIANT-2 Trial," 76th Annual Scientific Meeting of the American-College-of-Gastroenterology, Washington, Kiribati, 2011
Hobday, Timothy Et Al. "Post-Progression Therapies in Patients with Advanced Neuroendocrine Tumors (NET): Analysis From the RADIANT-2 Trial." 76th Annual Scientific Meeting of the American-College-of-Gastroenterology , Washington, Kiribati, 2011
Hobday, T. Et Al. (2011) . "Post-Progression Therapies in Patients with Advanced Neuroendocrine Tumors (NET): Analysis From the RADIANT-2 Trial." 76th Annual Scientific Meeting of the American-College-of-Gastroenterology , Washington, Kiribati.
@conferencepaper{conferencepaper, author={Timothy Hobday Et Al. }, title={Post-Progression Therapies in Patients with Advanced Neuroendocrine Tumors (NET): Analysis From the RADIANT-2 Trial}, congress name={76th Annual Scientific Meeting of the American-College-of-Gastroenterology}, city={Washington}, country={Kiribati}, year={2011}}